EN 
VN 
Recommendations, Consensus and Opinions, Document
EARLY DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL CANCER THROUGH REGULAR HEALTH CHECKUPS
Feb
Esophageal cancer is a serious malignancy, often detected late due to a lack of clear symptoms in the early stages, with a 5-year survival rate of less than 20%. However, with advances in medicine, especially gastrointestinal endoscopy, early detection and treatment of esophageal cancer have become possible, offering many patients a chance of complete cure.
Recommendations, Consensus and Opinions, Document
Survey of colorectal motility in patients with constipation using contrast-enhanced capsules at the Gastroenterology - Hepatology Center, Bach Mai Hospital
Feb
Determining the prevalence of colorectal motility disorders using contrast-enhanced capsules and some related factors in patients with constipation at the Gastroenterology - Hepatology Center, Bach Mai Hospital.
Recommendations, Consensus and Opinions, Document
M2BPGi (Mac-2 Binding Protein Glycosylation Isomer) is a novel, non-invasive biomarker for assessing liver fibrosis and predicting liver cancer risk
Feb
Cirrhosis and liver cancer are among the leading causes of death in Vietnam, with some of the highest incidence rates in the Asia-Pacific region. Early diagnosis plays a crucial role in treatment and improving the quality of life for patients. In a collective effort to address this challenge, M2BPGi – a blood biomarker test – promises a breakthrough in the early diagnosis of liver cancer and cirrhosis.